ANB-010
/ Biocad
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 25, 2025
EDELWEISS: A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A
(clinicaltrials.gov)
- P1/2 | N=50 | Active, not recruiting | Sponsor: Biocad | Recruiting ➔ Active, not recruiting
Enrollment closed • Hematological Disorders • Hemophilia • Hemophilia A • Rare Diseases
December 29, 2023
EDELWEISS: A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A
(clinicaltrials.gov)
- P1/2 | N=50 | Recruiting | Sponsor: Biocad
New P1/2 trial • Hematological Disorders • Hemophilia • Rare Diseases
1 to 2
Of
2
Go to page
1